MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
The role of proprioceptive deficits as a mechanism of gait impairments in postural instability and gait disorder Parkinson’s disease subtype

M.P. Pereira, P.H.S. Pelicioni, Q.J. Almeida, L.T.B. Gobbi (Leuven, Belgium)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
The sense of agency is altered in cervical dystonia

C. Delorme, E. Roze, D. Grabli, J.M. Mayer, B. Degos, M. Vidailhet, Y. Worbe (Paris, France)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
The serum response factor SRF protect dopamine (DA) neurons in Parkinson’s disease partially by mediate autophagy through a beclin 1-dependent pathway

X. Cheng (Suzhou, People's Republic of China)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
The systemic synuclein sampling study (S4)

D. Jennings, C. Coffey, T. Beach, T. Foroud, C.H. Adler, B. Mollenhauer, J. Seibyl, D. Ecklund, S. Lasch, V. Arnedo, C. Kopil (New Haven, CT, USA)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
The unfolded protein response pathway as a possible therapeutic target for the synucleinopathies

J.H. Baek, E. Bereczki, D. Aarsland (Stockholm, Sweden)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
The writer’s cramp and its connections with sensory deficits

F.C. Paquet, A. Kreisler, A. Bartolo (Fouquières-Lès-Lens, France)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II

R. López-Castellanos, R. López-Contreras (San Salvador, El Salvador)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Therapeutic potential of compounds preferring specific GABAA receptor subunits for the treatment of dystonia?

F. Richter, C. Bode, C. Spröte, A. Bauer, A. Richter (Leipzig, Germany)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Therapeutic protocol for Parkinson’s patient with freezing based on action observation plus sonification: Preliminary results

S. Mezzarobba, M. Grassi, M. Catalan, L. Pellegrini, R. Valentini, B. Krüger, P. Manganotti, P. Bernardis (Trieste, Italy)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Therapeutic yoga improves balance and balance confidence in Parkinson’s disease

F. Revilla, K. Woschkolup, A.A. Walter, B.L. Hawkins, E. Urrea-Mendoza, A.A. Schmid, J. Park, J. Sharp, M. VanPuymbroeck (Greenville, SC, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley